TORNTPHARMPharmaceuticals
Torrent Pharmaceuticals Ltd — Balance Sheet
₹4220.20
-0.74%
Torrent Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible Book Value | 2.99K Cr | 1.94K Cr | 771.06 Cr | 2.15K Cr | — |
| Invested Capital | 10.62K Cr | 10.79K Cr | 11.50K Cr | 9.97K Cr | — |
| Working Capital | 905.38 Cr | 186.23 Cr | -133.58 Cr | 749.90 Cr | — |
| Net Tangible Assets | 2.99K Cr | 1.94K Cr | 771.06 Cr | 2.15K Cr | — |
| Capital Lease Obligations | 176.23 Cr | 84.52 Cr | 71.26 Cr | 51.55 Cr | — |
| Common Stock Equity | 7.59K Cr | 6.86K Cr | 6.20K Cr | 5.95K Cr | — |
| Total Capitalization | 8.78K Cr | 8.46K Cr | 8.69K Cr | 8.08K Cr | — |
| Total Equity Gross Minority Interest | 7.59K Cr | 6.86K Cr | 6.20K Cr | 5.95K Cr | — |
| Stockholders Equity | 7.59K Cr | 6.86K Cr | 6.20K Cr | 5.95K Cr | — |
| Other Equity Interest | 7.42K Cr | 6.69K Cr | 6.03K Cr | 5.87K Cr | — |
| Capital Stock | 169.23 Cr | 169.23 Cr | 169.23 Cr | 84.62 Cr | — |
| Common Stock | 169.23 Cr | 169.23 Cr | 169.23 Cr | 84.62 Cr | — |
| Total Liabilities Net Minority Interest | 7.40K Cr | 8.20K Cr | 8.81K Cr | 7.15K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.68K Cr | 2.78K Cr | 3.37K Cr | 2.73K Cr | — |
| Derivative Product Liabilities | 0.55 Cr | 0.24 Cr | 9.11 Cr | 0.00 | — |
| Non Current Deferred Revenue | 0.46 Cr | 0.96 Cr | 1.46 Cr | 1.96 Cr | — |
| Non Current Deferred Taxes Liabilities | 828.72 Cr | 656.05 Cr | 401.94 Cr | 193.56 Cr | — |
| Long Term Debt And Capital Lease Obligation | 1.34K Cr | 1.67K Cr | 2.55K Cr | 2.16K Cr | — |
| Long Term Capital Lease Obligation | 145.86 Cr | 64.46 Cr | 52.93 Cr | 36.82 Cr | — |
| Long Term Debt | 1.19K Cr | 1.60K Cr | 2.50K Cr | 2.12K Cr | — |
| Long Term Provisions | 501.27 Cr | 444.69 Cr | 393.06 Cr | 368.74 Cr | — |
| Current Liabilities | 4.72K Cr | 5.43K Cr | 5.45K Cr | 4.42K Cr | — |
| Other Current Liabilities | 136.00 Cr | 130.00 Cr | 103.00 Cr | 99.00 Cr | — |
| Current Debt And Capital Lease Obligation | 1.86K Cr | 2.35K Cr | 2.82K Cr | 1.91K Cr | — |
| Current Capital Lease Obligation | 30.37 Cr | 20.06 Cr | 18.33 Cr | 14.73 Cr | — |
| Current Debt | 1.83K Cr | 2.33K Cr | 2.80K Cr | 1.89K Cr | — |
| Current Provisions | 408.13 Cr | 400.14 Cr | 393.71 Cr | 411.03 Cr | — |
| Payables | 2.35K Cr | 2.65K Cr | 2.11K Cr | 2.04K Cr | — |
| Other Payable | 432.58 Cr | 384.43 Cr | 394.06 Cr | 316.32 Cr | — |
| Dividends Payable | 4.93 Cr | 3.86 Cr | 4.80 Cr | 4.44 Cr | — |
| Total Tax Payable | 95.57 Cr | 167.93 Cr | 31.31 Cr | 41.48 Cr | — |
| Accounts Payable | 1.82K Cr | 2.09K Cr | 1.68K Cr | 1.67K Cr | — |
| Total Assets | 14.99K Cr | 15.06K Cr | 15.01K Cr | 13.10K Cr | — |
| Total Non Current Assets | 9.37K Cr | 9.45K Cr | 9.70K Cr | 7.93K Cr | — |
| Other Non Current Assets | 42.00 Cr | 15.00 Cr | 22.00 Cr | 26.00 Cr | — |
| Non Current Prepaid Assets | 22.74 Cr | 22.66 Cr | 20.27 Cr | 16.66 Cr | — |
| Non Current Deferred Taxes Assets | 594.15 Cr | 555.13 Cr | 543.67 Cr | 493.65 Cr | — |
| Financial Assets | 4.84 Cr | 4.38 Cr | 0.00 | 24.60 Cr | — |
| Investmentin Financial Assets | 44.57 Cr | 33.29 Cr | 71.11 Cr | 67.92 Cr | — |
| Available For Sale Securities | 44.57 Cr | 33.29 Cr | 71.11 Cr | 67.92 Cr | — |
| Goodwill And Other Intangible Assets | 4.60K Cr | 4.92K Cr | 5.43K Cr | 3.81K Cr | — |
| Other Intangible Assets | 4.26K Cr | 4.58K Cr | 5.09K Cr | 3.55K Cr | — |
| Goodwill | 338.88 Cr | 338.03 Cr | 337.50 Cr | 259.48 Cr | — |
| Net PPE | 3.86K Cr | 3.59K Cr | 3.48K Cr | 3.27K Cr | — |
| Accumulated Depreciation | -2.24K Cr | -2.03K Cr | -1.82K Cr | -1.92K Cr | — |
| Gross PPE | 6.10K Cr | 5.62K Cr | 5.30K Cr | 5.19K Cr | — |
| Construction In Progress | 409.09 Cr | 296.18 Cr | 710.71 Cr | 570.27 Cr | — |
| Other Properties | 298.94 Cr | 284.61 Cr | 245.55 Cr | 255.14 Cr | — |
| Machinery Furniture Equipment | 2.89K Cr | 2.65K Cr | 2.35K Cr | 2.34K Cr | — |
| Buildings And Improvements | 1.72K Cr | 1.61K Cr | 1.23K Cr | 1.24K Cr | — |
| Land And Improvements | 780.50 Cr | 779.75 Cr | 759.83 Cr | 791.84 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 5.62K Cr | 5.61K Cr | 5.31K Cr | 5.16K Cr | — |
| Other Current Assets | 336.00 Cr | 304.00 Cr | 303.00 Cr | 312.00 Cr | — |
| Hedging Assets Current | 5.30 Cr | 25.16 Cr | 0.00 | 85.59 Cr | — |
| Restricted Cash | 4.93 Cr | 3.86 Cr | 4.80 Cr | 4.44 Cr | — |
| Prepaid Assets | 135.15 Cr | 113.09 Cr | 126.56 Cr | 115.98 Cr | — |
| Inventory | 2.54K Cr | 2.28K Cr | 2.23K Cr | 2.46K Cr | — |
| Other Inventories | 63.19 Cr | 61.05 Cr | 57.26 Cr | 57.62 Cr | — |
| Finished Goods | 1.68K Cr | 1.43K Cr | 1.30K Cr | 1.39K Cr | — |
| Work In Process | 167.19 Cr | 140.95 Cr | 116.47 Cr | 177.59 Cr | — |
| Raw Materials | 628.24 Cr | 643.12 Cr | 752.49 Cr | 841.24 Cr | — |
| Other Receivables | 259.43 Cr | 246.93 Cr | 181.91 Cr | 197.18 Cr | — |
| Taxes Receivable | 122.09 Cr | 95.07 Cr | 104.24 Cr | 84.05 Cr | — |
| Accounts Receivable | 1.87K Cr | 1.84K Cr | 1.94K Cr | 1.63K Cr | — |
| Allowance For Doubtful Accounts Receivable | -12.24 Cr | -11.21 Cr | -10.85 Cr | -7.73 Cr | — |
| Gross Accounts Receivable | 1.88K Cr | 1.86K Cr | 1.95K Cr | 1.64K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 687.97 Cr | 1.00K Cr | 722.75 Cr | 582.95 Cr | — |
| Other Short Term Investments | 114.49 Cr | 168.86 Cr | 214.22 Cr | 184.55 Cr | — |
| Cash And Cash Equivalents | 573.48 Cr | 835.14 Cr | 508.53 Cr | 398.40 Cr | — |
| Cash Equivalents | 231.52 Cr | 399.29 Cr | 37.98 Cr | 22.81 Cr | — |
| Cash Financial | 341.96 Cr | 435.85 Cr | 470.55 Cr | 375.59 Cr | — |
| Ordinary Shares Number | 33.84 Cr | 33.84 Cr | 33.84 Cr | 33.84 Cr | — |
| Share Issued | 33.84 Cr | 33.84 Cr | 33.84 Cr | 33.84 Cr | — |
| Net Debt | 2.45K Cr | 3.10K Cr | 4.79K Cr | 3.62K Cr | — |
| Total Debt | 3.20K Cr | 4.02K Cr | 5.37K Cr | 4.07K Cr | — |
| Retained Earnings | — | 3.94K Cr | 3.30K Cr | 2.92K Cr | 2.81K Cr |
| Additional Paid In Capital | — | 71.43 Cr | 107.14 Cr | 147.20 Cr | 220.41 Cr |
| Other Non Current Liabilities | — | 1.00 Cr | 2.00 Cr | 4.00 Cr | 5.00 Cr |
| Tradeand Other Payables Non Current | — | — | — | 2.46 Cr | 6.35 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Torrent Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.